Houlihan Lokey (NYSE:HLI) Price Target Increased to $190.00 by Analysts at UBS Group

Houlihan Lokey (NYSE:HLI) had its price target raised by UBS Group from $170.00 to $190.00 in a research report sent to investors on Tuesday, Benzinga reports. UBS Group currently has a buy rating on the financial services provider’s stock.

A number of other analysts have also recently commented on the stock. Morgan Stanley upped their target price on shares of Houlihan Lokey from $146.00 to $163.00 and gave the company an equal weight rating in a report on Monday, September 23rd. Keefe, Bruyette & Woods restated a market perform rating and issued a $154.00 price objective (up from $139.00) on shares of Houlihan Lokey in a research note on Wednesday, July 31st. JPMorgan Chase & Co. lowered their target price on Houlihan Lokey from $132.00 to $129.00 and set a neutral rating on the stock in a research report on Wednesday, July 31st. Finally, Wells Fargo & Company started coverage on Houlihan Lokey in a research report on Thursday, September 12th. They issued an underweight rating and a $149.00 price target for the company. One analyst has rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of Hold and a consensus price target of $157.00.

Houlihan Lokey Price Performance

NYSE HLI opened at $163.85 on Tuesday. Houlihan Lokey has a 1-year low of $94.67 and a 1-year high of $164.49. The stock has a market capitalization of $11.24 billion, a price-to-earnings ratio of 39.87 and a beta of 0.66. The business’s fifty day moving average price is $153.95 and its 200-day moving average price is $140.61.

Houlihan Lokey (NYSE:HLI) last announced its earnings results on Tuesday, July 30th. The financial services provider reported $1.22 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.22. The business had revenue of $514.00 million for the quarter, compared to analysts’ expectations of $508.70 million. Houlihan Lokey had a return on equity of 18.80% and a net margin of 15.30%. The business’s revenue for the quarter was up 23.6% on a year-over-year basis. During the same period last year, the firm posted $0.89 earnings per share. Equities research analysts anticipate that Houlihan Lokey will post 5.54 EPS for the current year.

Houlihan Lokey Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Sunday, September 15th. Investors of record on Tuesday, September 3rd were paid a dividend of $0.57 per share. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.39%. The ex-dividend date was Tuesday, September 3rd. Houlihan Lokey’s dividend payout ratio (DPR) is 55.47%.

Insiders Place Their Bets

In other Houlihan Lokey news, General Counsel Christopher M. Crain sold 1,000 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $155.29, for a total transaction of $155,290.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, Director Gillian Beth Zucker sold 200 shares of the company’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of $152.28, for a total transaction of $30,456.00. Following the completion of the transaction, the director now owns 6,801 shares in the company, valued at approximately $1,035,656.28. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, General Counsel Christopher M. Crain sold 1,000 shares of Houlihan Lokey stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $155.29, for a total transaction of $155,290.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 9,717 shares of company stock worth $1,479,513. Corporate insiders own 25.97% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. lifted its position in shares of Houlihan Lokey by 0.6% in the first quarter. Vanguard Group Inc. now owns 5,104,143 shares of the financial services provider’s stock worth $654,300,000 after buying an additional 29,843 shares in the last quarter. Earnest Partners LLC increased its stake in Houlihan Lokey by 1.9% in the 2nd quarter. Earnest Partners LLC now owns 3,273,818 shares of the financial services provider’s stock worth $441,507,000 after acquiring an additional 62,314 shares during the last quarter. Kayne Anderson Rudnick Investment Management LLC raised its holdings in shares of Houlihan Lokey by 1.3% during the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 3,087,898 shares of the financial services provider’s stock worth $416,434,000 after acquiring an additional 38,155 shares in the last quarter. Sei Investments Co. boosted its position in shares of Houlihan Lokey by 6.2% during the 2nd quarter. Sei Investments Co. now owns 776,335 shares of the financial services provider’s stock valued at $104,697,000 after acquiring an additional 45,205 shares during the last quarter. Finally, Bank of New York Mellon Corp boosted its position in shares of Houlihan Lokey by 1.2% during the 2nd quarter. Bank of New York Mellon Corp now owns 517,952 shares of the financial services provider’s stock valued at $69,851,000 after acquiring an additional 6,291 shares during the last quarter. Institutional investors own 78.07% of the company’s stock.

Houlihan Lokey Company Profile

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.